Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-01-26

Clinical Trial Update: The Prevention of Erythropoietin on Cardiac Surgery-associated Acute Kidney Injury [NA]

View source ↗

Summary

Clinical trial about prevention of erythropoietin on cardiac surgery-associated acute kidney injury; status terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Erythropoietin (erythropoietin)

Snippet

Sponsor: Nanjing First Hospital, Nanjing Medical University | Conditions: Acute Kidney Injury, Cardiac Disease | NA | Status: TERMINATED | Results posted: 2023-01-26